MV
Maulikkumar Vallabhabhai Kaneria
About Maulikkumar Vallabhabhai Kaneria
Data last updated:
Maulikkumar Vallabhabhai Kaneria is a Director at Silvercrest Ventures Private Limited (since 2022) and Director at Sorath Healthcare Private Limited (since 2023). The companies operate in Healthcare. The largest current company by reported revenue is Silvercrest Ventures Private Limited at ₹12.5 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 23 Aug 2022 | 2022 | ₹12.5 Lakh (FY 2025) | Active | |
| Director | 01 Mar 2023 | 2023 | Active |
Board colleagues of Maulikkumar Vallabhabhai Kaneria
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Maulikkumar Vallabhabhai Kaneria
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Maulikkumar Vallabhabhai Kaneria
Maulikkumar Vallabhabhai Kaneria currently holds 2 directorships: Silvercrest Ventures Private Limited (Director, since 23 Aug 2022, revenue ₹12.5 Lakh (FY 2025)); Sorath Healthcare Private Limited (Director, since 01 Mar 2023).
Maulikkumar Vallabhabhai Kaneria was first appointed on 23 Aug 2022 as Director at Silvercrest Ventures Private Limited. The most recent appointment on record is 01 Mar 2023 at Sorath Healthcare Private Limited.
The current boards of Maulikkumar Vallabhabhai Kaneria's companies include Akash Chandulal Patoliya (Silvercrest Ventures Private Limited), Chintan Maganlal Mori (Silvercrest Ventures Private Limited), Janakkumar Parsotam Dharasandiya (Silvercrest Ventures Private Limited), Jaychandra Nareshkumar Ratanpara (Silvercrest Ventures Private Limited), Kunjan Mohanlal Detroja (Silvercrest Ventures Private Limited), Maulik Babulal Bhalodia (Silvercrest Ventures Private Limited), among others.